From Business model to Business model portfolio in the european biopharmaceutical industry - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Long Range Planning Année : 2010

From Business model to Business model portfolio in the european biopharmaceutical industry

Résumé

At the crossroad of firm's core competencies and of the anticipations of consumers' needs, the business model approach complements corporate and business strategy approaches. Firms combine several business models simultaneously to deliver value to different markets, building a portfolio of business model. For managers, business model and business model portfolio are particularly useful to address customer's needs and organisational capabilities of the firm. They also emphasise how the initial core competency of the firm can be extended or redeployed to increase the rent. Business model portfolio describes the firm's strategy to balance time-to-market, revenue stream, risk and interdependencies. It conceptualises firm diversification within the same industry to generate and capture rents. They finally describe two generic dimensions: core competence extension to enlarge the market and to address additional customers and core competence redeployment to serve similar market with the same core competence.
Fichier principal
Vignette du fichier
Business_Model_Portfolio_V7_2_.pdf (167.21 Ko) Télécharger le fichier
Film_business_model_HAL.flv (15.58 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Format : Vidéo
Loading...

Dates et versions

hal-00430782 , version 1 (09-11-2010)

Identifiants

Citer

Valérie Sabatier, Vincent Mangematin, Tristan Rouselle. From Business model to Business model portfolio in the european biopharmaceutical industry. Long Range Planning, 2010, 43 (2-3), pp.431-447. ⟨10.1016/j.lrp.2010.02.001⟩. ⟨hal-00430782⟩
374 Consultations
3506 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More